AGP 9MCY26 profit dips 9%
Mettis Global • • 1 min read

AGP Limited recorded consolidated net earnings of Rs2.59 billion for the nine months to September 30, 2026, down 9.4% from Rs2.85 billion a year earlier, Mettis Global reported. Earnings per share eased to Rs8.29 from Rs8.92. In the third quarter alone, profit was Rs1.03 billion, compared with Rs1.18 billion in the same quarter of 2025.
Revenue fell 11.6% to Rs17.98 billion, while gross profit decreased 8.9% to Rs11.02 billion; the gross margin nevertheless widened to 61.28% from 59.44%. Profit before tax dropped 22% to Rs3.53 billion, with lower tax expense partly offsetting the decline in earnings. For PSX investors, the results provide an update on AGP’s performance and earnings in the pharmaceutical sector.
At a glance
- AGP’s nine-month net profit fell 9.4% to Rs2.59 billion.
- Revenue declined 11.6% to Rs17.98 billion.
- Earnings per share decreased to Rs8.29 from Rs8.92.
Stocks in this story
Originally reported by Mettis Global
This page is Investify's own summary. The full report, with all details and context, is on the publisher's site.
Read the full storyWant the full article here?
Log in to read the full article in the Investify reader, in English or Urdu.
Investify summarizes Pakistan Stock Exchange news in its own words and links each story to its original publisher. We always credit the source so you can read the full report and verify the details before making financial decisions.
More on AGP
PACRA retains AGP’s long-term rating at A+Mettis• 27 Oct 2026Neutral coverage
Asian markets mixed, tech stocks tumble on US earnings missesMettis• 30 Oct 2026
HALEON begins Panadol 500mg manufacturing in JamshoroMettis• 30 Oct 2026
Citi Pharma acquires 20% stake in Pakheim InternationalMettis• 30 Oct 2026
Industry seeks NAB probe into alleged overpriced coal purchases at Port Qasim power plantProfit• 30 Oct 2026
New provinces to carry heavy cost: think tankDawn• 30 Oct 2026
